PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
25-Feb-2022 Eagle Genomics Continues Strategic Global Expansion with Three New Appointments in UK and India Eagle Genomics
25-Feb-2022 Cassiopea SpA announces approval of delisting of its shares on SIX Swiss Exchange Cassiopea S.p.A.
24-Feb-2022 EMA Committee for Medicinal Products for Human Use (CHMP) Adopts Positive Opinion Recommending Authorization for The Use of The Moderna Covid-19 Vaccine in Children (6-11 Years) In the European Union Moderna, Inc.
24-Feb-2022 ProQR Announces Fourth Quarter and Full Year 2021 Operating and Financial Results ProQR
24-Feb-2022 Sernova Ranks Among Top 50 Performing Companies on the 2022 TSX Venture List Sernova Corp.
24-Feb-2022 Notice to Convene the Annual General Meeting of Genmab A/S Genmab A/S
24-Feb-2022 Original-Research: Haemato AG (von First Berlin Equity Research GmbH) Haemato AG
24-Feb-2022 Biotage Awarded Gold Sustainability Medal by EcoVadis Biotage
24-Feb-2022 OKYO Pharma ("OKYO" or the "Company") - announces issuance of U.S. Patent No. 11,254,720 covering OKYO’s dry eye drug candidate OK-101 for use to treat ocular neuropathic pain OKYO Pharma
24-Feb-2022 Theragnostics Announces US FDA Approval for its Radiodiagnostic Imaging Drug NephroScanTM (Kit for the Preparation of Technetium Tc 99m Succimer Injection) Theragnostics
24-Feb-2022 Voluntis Announces Partnership with Tilak Healthcare to Help Patients with Cancer Better Manage Ocular Toxicities Voluntis
24-Feb-2022 Ardelyx’s tenapanor has potential to capture a slice of the CKD-HP market, says GlobalData Ardelyx
24-Feb-2022 Original-Research: MPH Health Care AG (von First Berlin Equity Research GmbH) MPH Health Care AG
23-Feb-2022 Cheplapharm AG: Jens Rothstein hands over his CFO role to Kia Parssanedjad Cheplapharm AG
23-Feb-2022 Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care published form 20-F for the fiscal year 2021 Fresenius Medical Care AG & Co. KGaA
23-Feb-2022 Lilly Announces the Institute for Genetic Medicine and $700 Million investment in Boston Seaport Site Lilly
23-Feb-2022 Vifor Pharma reports sustained growth in 2021 Vifor Pharma
23-Feb-2022 Darolutamide plus androgen deprivation therapy and docetaxel significantly increases overall survival in patients with metastatic hormone-sensitive prostate cancer Orion Corporation
23-Feb-2022 Completion of sale of Gyroscope Therapeutics Syncona Ltd
23-Feb-2022 Almirall launches innovative Wynzora® CAL/BDP cream in Europe for the treatment of mild to moderate plaque psoriasis in adults including scalp Almirall